ABL Texcell Diagnostics SA (ENXTPA: ABLD)
Industrials · Trading Companies & Distributors · FR
€2.52
+9.57% today · -44.2% 1Y
ABL Texcell Diagnostics SA (ENXTPA: ABLD) operates in the Trading Companies & Distributors industry within the Industrials sector. The company is valued at $45.56M and employs 22 people.
Over the last twelve months the share price has lost 44.2%, trading between 2.10 and 5.00.
Tweenvest scores ABL Texcell Diagnostics SA across four factors: quality 53/100, value 55/100, dividend 40/100. Its strongest factor is value.
ABLD price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $45.56M
- Revenue (TTM)
- $12.71M
- P/E
- —
- EPS
- —
- Dividend yield
- 4.37%
- Beta (5Y)
- -0.53
- 52-week high
- €5.00
- 52-week low
- €2.10
- Avg volume (3M)
- —
- Shares outstanding
- 16.07M
- Employees
- 22
- Next earnings
- —
About ABL Texcell Diagnostics SA
ABL Diagnostics Société anonyme provides proprietary molecular biology assays and end-to-end solutions to be used for molecular detection by polymerase chain reaction (PCR) and through DNA sequencing in France and internationally. The company offers genotyping through NGS and sanger sequencing for human immunodeficiency virus, SARS CoV-2, hepatitis-C virus, mycobacterium tuberculosis, and 16S/18S RNA; ultragene assays for viral detection of SARS CoV-2, MonkeyPox, and Clostridium; microbiological specimen transport and collection kits, which include saliva preservation, wastewater collection, and surface collection kits, as well as inactivation and preservation solution; and instrument and consumables, such as DNA/RNA extraction system, real-time PCR system, liquid handling robot, NGS library preparation kit, and sanger sequencing reaction. It also provides digital solutions comprising analysis software, data hosting, lab automation, Nadis, and SeqHepB. The company sells its products directly, as well as through a network of distributors to academic clinical pathology labs, private reference labs, and researchers. The company was formerly known as Etablissements Fauvet Girel and changed its name to ABL Diagnostics Société anonyme in April 2022. The company is headquartered in Woippy, France. ABL Diagnostics Société anonyme is a subsidiary of Advanced Biological Laboratories (ABL) S.A.
- ISIN
- FR001400AHX6
- Listed since
- Dec 12, 2000
- Exchange
- Euronext Paris
- Currency
- EUR
Other Trading Companies & Distributors companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| ProService Building Services Marketplace PlcAIM: PRO | $46.67M | £0.04 | +2.33% |
| Hatsuho Shouji Co.,Ltd.TSE: 7425 | $46.24M | ¥1,104.00 | -0.99% |
| Grupo Pochteca, S.A.B. de C.V.BMV: POCHTEC B | $45.87M | MX$6.50 | +0.78% |
| Tak Lee Machinery Holdings LimitedSEHK: 2102 | $45.87M | HK$0.36 | +1.41% |
| Design Capital LimitedSEHK: 1545 | $45.36M | HK$0.18 | -0.56% |
| Trishakti Industries LimitedBSE: 531279 | $45.28M | Rs260.80 | +3.16% |
| Averbuch Formica Center Ltd.TASE: AVER | $45.06M | ₪19.90 | -1.92% |
| Kitazawa Sangyo Co., Ltd.TSE: 9930 | $44.86M | ¥381.00 | -0.52% |
Figures last refreshed Oct 18, 2026.